Vitamin D dependent rickets type II with myelofibrosis and immune dysfunction
- 1 July 1991
- journal article
- case report
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 150 (9), 665-668
- https://doi.org/10.1007/bf02072630
Abstract
We present a new patient with vitamin D dependent rickets type II. A 20-month-old Arabian boy whose parents are first cousins showed florid rickets, myelofibrosis and recurrent septicaemia. In addition to absent specific binding for 1,25-dihydroxyvitamin D3 (1,25(OH)2D3). 25-Hydroxyvitamin D3-24-hydroxylase activity could not be induced in cultured fibroblasts. The patient did not respond to 99 μg 1,25(OH)2D3 per day, but skeletal and haematological abnormalities improved with daily infusion of 100 mg/kg calcium, as serum parathyroid hormone levels fell to normal values. At the age of 7 years, he died from pneumonia. The improvement of haematological abnormalities with calcium infusions but not with 1.25(OH)2D3 suggests a pathogenetic relationship of myelofibrosis and hyperparathyroidism. Having antilipid A IgM antibody titres up to 1∶10.000 after Gram negative septicaemias, the patient never produced corresponding IgG antibodies. His neutrophil chemotaxis was persistently reduced to 57%±3% of age-matched controls (P<0.028). The patient showed two pathological immune functions considered to contribute to the well-known susceptibility to infection in rickets.Keywords
This publication has 15 references indexed in Scilit:
- Long-term intracaval calcium infusion therapy in end-organ resistance to 1,25-dihydroxyvitamin DAmerican Journal Of Medicine, 1987
- Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D.Journal of Clinical Investigation, 1986
- Interactions of 1,25-dihydroxyvitamin D3 and the immune systemMolecular and Cellular Endocrinology, 1985
- Vitamin D-dependent rickets type II. Defective induction of 25-hydroxyvitamin D3-24-hydroxylase by 1,25-dihydroxyvitamin D3 in cultured skin fibroblasts.Journal of Clinical Investigation, 1985
- A ROLE FOR 1,25-DIHYDROXYVITAMIN D3 IN CONTROL OF BONE-MARROW COLLAGEN DEPOSITION?The Lancet, 1984
- Lipid a antibody determinations using ELISA on patients at a children's hospital: A preliminary reportInfection, 1983
- Resistance to 1,25-dihydroxyvitamin D. Association with heterogeneous defects in cultured skin fibroblasts.Journal of Clinical Investigation, 1983
- Myeloid Metaplasia in Vitamin D Deficiency RicketsScandinavian Journal of Haematology, 1982
- 1,25-Dihydroxyvitamin D3 and the regulation of macrophage functionCalcified Tissue International, 1981
- PARATHYROID HORMONE AND EXPERIMENTAL OSTEOSCLEROSISThe Lancet, 1970